Screener
Gyre Therapeutics, Inc. GYRE Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
FAQ
- What is Gyre Therapeutics, Inc.'s operating lease liabilities (total)?
- Gyre Therapeutics, Inc. (GYRE) reported operating lease liabilities (total) of $3.42M in Q2 2026.
- How has Gyre Therapeutics, Inc.'s operating lease liabilities (total) changed year-over-year?
- Gyre Therapeutics, Inc.'s operating lease liabilities (total) increased by 145.4% year-over-year, from $1.39M to $3.42M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s operating lease liabilities (total) has grown at a -10.6% compound annual growth rate (CAGR), from $1.64M to $939K.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.
Ask your AI about Gyre Therapeutics, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude